The BOC Group, a provider of industrial gases and vacuum technologies, has cut a multiyear deal with supply chain management company Novation to offer bulk and compressed gases to members and affiliates of VHA and the University Health System Consortium
The BOC Group, a provider of industrial gases and vacuum technologies, has cut a multiyear deal with supply chain management company Novation to offer bulk and compressed gases to members and affiliates of VHA and the University Health System Consortium (UHC). Prior to the deal, BOC had long-standing supply contracts with many members of VHA, a national healthcare alliance. Under the terms of the new agreement, BOC will renew its contracts with VHA, which are estimated to account for more than $100 million in sales, and offer its services to the balance of VHA's membership as well as UHC's member academic medical centers, which number close to 200. The contract allows VHA and UHC members to choose among a set of optional services such as BOC's proprietary Tel-Tank telemetry system for remote monitoring of onsite bulk storage tanks, vendor-managed inventory systems that handle customers' gas and equipment requirements, and a variety of eBusiness tools designed to reduce costs.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.